Come Together

Late Breaker! $NRSN finance.yahoo.com/news/neurosens…

Today: linkedin.com/posts/neurosen…

Also today: the Late Breaker. Phenomenal data to follow. $NRSN Stay tuned. 🚀🧠 linkedin.com/posts/neurosen…

$NRSN Announces Transformative Phase 2b MicroRNA Data, Highlighting PrimeC's Promise as a Disease-Modifying ALS Treatment. 🧠 👇 finance.yahoo.com/news/neurosens…

Today around 1:40pm est, on TV i24NEWS English : I’ll be sharing our journey developing a promising therapy for ALS. From what we’ve achieved with PrimeC to where we’re headed next - hope is in motion. 🌍🧠 #ALS #biotech #PrimeC #NeuroSense $NRSN i24news.tv/en

$NRSN – Initial updates: Making progress on all fronts. Catch PrimeC featured on i24NEWS English yesterday - advancing hope in ALS. #ALS #PrimeC #NeuroSense #biotech youtu.be/i84GorK0ZDU?si…

$NRSN Today I shared a letter to shareholders providing an overview and updates on how we're advancing on multiple fronts, including Phase 3 preparations for PrimeC in ALS, Canadian regulatory pathway progress, our recent clinical validation, and our ongoing partnership

I’m the Luckiest Man on Earth. This ALS Awareness Month, we honor the strength of patients & families - and keep pushing forward. At @NeuroSenseTX, every step we take is for them - and yes, we’re on the right path, on all fronts. #ALSAwarenessMonth #ALS #Hope #PrimeC $NRSN

$NRSN Good news, and more to come. finance.yahoo.com/news/neurosens…

$NRSN Got a few questions today about whether we're planning a private placement. 🤨 The plain answer: No. Now's not the time. We believe there are better options ahead for the company - and we're focused on those.

Full steam ahead! We're ramping up manufacturing with our partners at Recipharm to ensure we're ready for market. Looking forward to big updates very soon. Stay tuned! $NRSN

$NRSN A lot is going on at NeuroSense Therapeutics. Here are some updates of what we did in the second quarter of this year. Watch here 👇 youtu.be/bo4ZNja0Pqc?si…

You are more than welcome to submit your questions before or during the live event. 🙂 $NRSN

Do You Remember? 💜 $NRSN for Alzheimer’s youtu.be/1v57o9qBqrM?si… via YouTube

Another step forward for PrimeC. Today we shared new biomarker findings from our PARADIGM study, showing that PrimeC significantly reduced several key microRNAs linked to Alzheimer’s disease biology - pathways related to neuroinflammation, amyloid and tau. While this reinforces

From PARADIGM to PARAGON: On October 10 at NEALS 2025, Prof. Merit Cudkowicz will unveil the design of our global Phase 3 PARAGON trial of PrimeC in ALS. Built on insights from our Phase 2b PARADIGM study, PARAGON is designed to rigorously confirm PrimeC’s potential to preserve

Heading to Southern California for a conference and several key meetings. I’ve left time open to connect with founders, researchers, clinicians, and investors working in ALS and neuroscience. DM me if you’d like to meet. #ALS #California $NRSN